Hims removes $49 weight loss drug from shelves, Novo Nordisk stock rises
Telemedicine company Hims & Hers announced over the weekend that it would shelve plans to launch its $49 compound weight-loss pill after facing legal action from Novo Nordisk and related warnings from the US Food and Drug Administration. In response to this news, Novo Nordisk's shares listed in Frankfurt rose by 4.5% on Monday.
Hims & Hers launched the weight-loss pill last Thursday, with its core ingredient being semaglutide—the same key component used in Novo Nordisk's blockbuster weight-loss and diabetes injections. This move immediately drew opposition from the Danish pharmaceutical company and regulatory authorities. On Saturday, Hims & Hers stated that after “constructive discussions” with relevant stakeholders, they would cease offering this weight-loss product.
Previously, US FDA Commissioner Marty Makary had already stated that there would be a strict crackdown on unapproved GLP-1 compound drugs, which have impacted Novo Nordisk’s pricing power in the weight-loss and diabetes markets. Following this statement, Novo Nordisk's stock rebounded more than 5% last Friday.
Despite the latest price surge, Novo Nordisk still faces enormous operational pressure: on one hand, it must contend with competition from Eli Lilly; on the other, it must directly face the impact of lower-priced compound alternatives. In its full-year earnings report released last week, the company pointed out that it is experiencing “unprecedented pricing pressure,” a comment that directly triggered a 17% plunge in its stock price.
Novo Nordisk’s market capitalization peaked in June 2024, but has since evaporated by nearly two-thirds.
Editor: Li Zhaofu
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tonight, a "dovish rate hike"?
The Federal Reserve is almost certain to raise interest rates tonight, but the key issue is "what will be said after the hike." Citi characterizes this move as a "fine-tuning" adjustment, suggesting there is no inevitable future rate hike, yet warns that if Chairman Powell does not provide clear forward guidance, it will trigger significant market volatility. Goldman Sachs bluntly stated that there is insufficient economic foundation for this rate hike, with inflation being merely a one-off factor, and expects this to be a "signal-less rate hike."
JPMorgan: "Open source disruption" and "AI safety" are not issues, there is still room for capital expenditure in the next two years, semiconductor equipment will become the "new bottleneck"
JPMorgan believes that open-source models are not a threat, regulatory disruptions are only short-term, and cloud vendors’ leverage remains low—the fundamentals of computing power investment have not changed. It forecasts that the capital expenditure of the seven major tech giants will soar from $443 billion in 2025 to $1.577 trillion in 2027, with semiconductor equipment becoming the core bottleneck of the supply chain and a new round of price increases expected in wafer foundry and advanced packaging.
Micron executive: Storage determines AI limits, substantial new capacity will come after 2028
Micron executive Sumit Sadana stated that memory bandwidth and capacity have become the core factors determining the performance ceiling of AI systems. In the face of structural imbalances between supply and demand, Micron expects to increase capital expenditure to over $45 billion in fiscal year 2027, but due to process complexity, substantive new capacity will not be released until 2028. Additionally, long-term supply agreements are reshaping the industry's business model, and humanoid robots will trigger the next wave of massive demand.
Goldman Sachs warns top clients: AI momentum trading shows unprecedented cracks, recommends hedging
Goldman Sachs has issued a rare warning to top clients: deep structural cracks are emerging in AI momentum. The AI-themed basket has dropped nearly 45% from its peak, with the one-day performance gap between short-term and long-term momentum reaching a five-year high. Capital is accelerating its shift from semiconductors to software. Goldman Sachs explicitly recommends that investors with AI exposure start hedging.
Crypto prices
More
